Related stories
Insulet Q3 Net Income Rises, Issues FY26 Outlook
Insulet reported third-quarter net income of $141.1 million, or $2.03 per diluted share, versus $87.6 million, or $1.24 per share, a year earlier. Adjusted net income rose 57.2% to
M impact | EARNINGS | Nov 04, 2026, 01:54 PM UTC
Kansai Nerolac Reports September-Quarter Consolidated Net Profit of 1.46 Billion Rupees
M impact | EARNINGS | Nov 04, 2026, 01:54 PM UTC
Cenovus Sees 2026 Capex at Top End or Slightly Above $5B-$5.3B Range
M impact | EARNINGS | Nov 04, 2026, 01:52 PM UTC
Novo Nordisk Raises 2026 Outlook as Wegovy Pill Rollout Speeds Up
Novo Nordisk raised its 2026 outlook and is speeding up the rollout of its Wegovy pill, according to the headline.
M impact | EARNINGS | Nov 04, 2026, 01:52 PM UTC
Grønlandsbanken Reports Higher Nine-Month Pretax Profit
Grønlandsbanken reported higher pretax profit for the first nine months of 2026.
L impact | EARNINGS | Nov 04, 2026, 01:52 PM UTC
Grønlandsbanken Nine-Month Pretax Profit Rises 9% to DKK 143.9 Million
M impact | EARNINGS | Nov 04, 2026, 01:51 PM UTC